Here are four things to know:
1. The market was valued at $2 billion in 2015.
2. The report notes the pain management devices market increases at three times the rate of the over-the counter internal analgesics segment as drug-free pain solutions are of increasing interest to consumers.
3. Technological advancements and expanding life spans have paved the way for market growth.
4. Pharmaceutical companies operating in the market include AstraZeneca, GlaxoSmithKline and Pfizer, among others.
More practice management news:
MGMA advocates for congressional oversight of CMMI: 5 notes
The last 30 years & counting — 5 key points on bundled payments
3 orthopedic clinics to pay $2.39M to settle False Claims Act allegations: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
